4//SEC Filing
Jackson Andrew C. 4
Accession 0001140361-22-022025
CIK 0000748592other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:01 PM ET
Size
5.4 KB
Accession
0001140361-22-022025
Insider Transaction Report
Form 4
Jackson Andrew C.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-06-03+664,800→ 664,800 totalExercise: $0.61Exp: 2032-06-03→ Common Stock, par value $0.005 per share (664,800 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable over four years (subject to continued service), with 25% of the shares vesting on May 31, 2023 and the remaining shares vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001636738
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:01 PM ET
- Size
- 5.4 KB